Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray (TLRY) earnings for the cannabis company's second quarter of 2020 have TLRY stock taking a beating after-hours Monday.
The post Tilray Earnings: TLRY Stock Falls 10% After Missing Q2 Estimates appeared first on InvestorPlace.

Tilray Earnings: TLRY Stock Falls 10% After Missing Q2 Estimates

Tilray Inc.'s TLRY, +6.83% cannabis sales did not grow as much as expected in the first full quarter of the COVID-19 pandemic, sending shares lower in after-hours trading Monday.

Tilray losses expand as pandemic pot sales disappoint, stock falls 7%

NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, reports financial results for the second quarter ended June 30, 2020.

Tilray, Inc. Reports 2020 Second Quarter Results

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

The U.S. Labor Department reported Friday that the unemployment rate fell to 10.2%.

Cresco Labs, Curaleaf, Green Thumb, Tilray: Here Are The Cannabis Companies Currently Hiring

Here's what analysts' are forecasting for Tilray's Q2 earnings report on Monday.

Tilray expects to report cannabis sales growth in the fiscal Q2

Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports second-quarter 2020 results.

Tilray (TLRY) to Report Q2 Earnings: What's in the Cards?

Tilray, Inc. (TLRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

Will Tilray, Inc. (TLRY) Report Negative Earnings Next Week?

Aurora Cannabis

Aphria

Canopy Growth

Trulieve Cannabis Corp.

Several cannabis companies such as Canopy Growth Corp. (NYSE: CGC), Tilray Inc. (NASDAQ: TLRY) and Aurora Cannabis Inc.

Here's Why Cannabis Stocks Are Getting A Boost

NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today it will report results for the second quarter ended June 30, 2020 on Monday, August 10, 2020 after market close.

Tilray to Report Second Quarter 2020 Financial Results on August 10, 2020

Cronos Group

Aurora Cannabis stock dipped after the company said it will cut staff in Europe by one quarter and scale back other operations.

Marijuana Stocks Fall Amid Industry's Latest International Pullback

Both of these pot stocks are struggling this year, but which one is more likely to turn things around?

Better Cannabis Stock to Buy: Tilray or Charlotte's Web?

GW Pharmaceuticals

HEXO Corp

Innovative Industrial Properties

As the coronavirus breakout was just beginning to be seen as a major threat to our health and to the economy back in March, it wasn’t clear what the implications might be to the cannabis industry, which was already struggling with a capital crunch that had intensified during the vaping crisis in.

Three Reasons To Be Bullish On Cannabis Stocks

The company's solution to high production costs is to scale up operations -- even while making cuts elsewhere.

Tilray Is Still Trying to Be a Growth Stock. Is It a Brilliant Strategy or a Misguided Move?

Amazon

Tesla

Dominion Energy

Tesla, Amazon, Dominion Energy, Sea Ltd and Tilray were our top stock trades for Tuesday. So, let's take a closer look at the charts now.

5 Top Stock Trades for Tuesday: TSLA, AMZN, TLRY, SE, D

The best defense during a market downturn is usually a good offense. Here are two high-growing cannabis companies that are likely to continue their momentum.

Which of These 2 Ultra-Growth Stocks Is Best?

Amyris

Cara Therapeutics

These marijuana stocks on the Nasdaq are top for value, growth, and performance for July 2020.

Top Marijuana Stocks on the NASDAQ for July 2020

GLJ Research founder Gordon Johnson joined Benzinga’s PreMarket Prep show on June 23.

Analyst Explains Why He's Bearish On Tilray And Aurora Cannabis, Recommends MSOs

Even after a robust rally in the overall market, Tilray stock still can't harness lasting momentum. I will continue to avoid TLRY stock.

Continue Avoiding Tilray Stock as Charts, Fundamentals Lag

OrganiGram Holdings Inc.

Amid recession and social unrest, the cannabis industry sees its moment.

Why more states could legalize cannabis in 2021

Although Tilray posted some impressive revenue gains, the bottom line is that the company is still losing money, making TLRY stock riskier than you might think.
The post Don’t Let Positive Revenue Confuse Your Outlook on Tilray appeared first on InvestorPlace.

Don’t Let Positive Revenue Confuse Your Outlook on Tilray

Tilray isn't out of the race by any means

Does Tilray Have the Right Stuff to Become a Global Leader?

Pot stock valuations have plummeted, and these CEOs could pay the price for this underperformance.

3 Cannabis Stock CEOs Who May Lose Their Jobs

Many cannabis investors may want to pick Aurora or Cronos instead of TLRY stock, but Tilray could continue growing going forward.
The post Why Tilray Is Still a Very Risky Cannabis Stock appeared first on InvestorPlace.

Why Tilray Is Still a Very Risky Cannabis Stock

Tilray, Inc.'s (TLRY) Management Presents at Oppenheimer 20th Annual Consumer Growth and E-Commerce Conference 2020 - Transcript

Although Tilray stock has looked interesting since hitting a sharp low in March, the viability of its long-term trajectory is a huge question mark.
The post Only the Most Daring Need Apply for Tilray appeared first on InvestorPlace.

News for Tilray Brands Stock (TLRY)